Determinants of delayed postoperative radiation therapy in breast cancer patients undergoing neoadjuvant chemotherapy: A subanalysis of the AMAZONA III prospective cohort
Key Points
Delayed postoperative radiation therapy is linked to patient and treatment factors, influencing overall treatment timelines.
The study reveals that 30% of patients experienced delays in radiation therapy following neoadjuvant chemotherapy.
Observational analysis of the AMAZONA III cohort highlights key determinants affecting radiation treatment schedules.
Addressing these delays is crucial, as timely radiation therapy can significantly impact patient outcomes.
Determinants of delayed postoperative radiation therapy in breast cancer patients undergoing neoadjuvant chemotherapy: A subanalysis of the AMAZONA III prospective cohort | Synapse